Immune System Diseases Active Not Recruiting Phase Trials for Ocrelizumab (DB11988)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03562975Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus